Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Lupin moves High Court...

    Lupin moves High Court fearing tax on pre-GST stock

    Written by Ruby Khatun Khatun Published On 2017-12-29T12:34:37+05:30  |  Updated On 29 Dec 2017 12:34 PM IST
    Lupin moves High Court fearing tax on pre-GST stock

    Mumbai: Lupin has filed a writ petition in Delhi High Court against the Government of India claiming the stock lying in its godowns could face double taxation at the time of selling.


    A recent report in ET states that Lupin is worried that the old pile of medicines, ointments or any other drugs, on which previous taxes such as sales tax and VAT have already been paid and lying in its godowns could face double taxation due to goods and services tax (GST) regulations mainly because many drugs and medicines that were manufactured before GST kicked in, were actually rolled out this year, and could carry an expiry date later than June 2018.


    Transitional credit is a concept under GST wherein taxes paid under the old regime can be set off against the GST liability.


    So, the pharma companies that bought medicines or other drugs from their vendors or third-party manufacturers without corresponding invoices before July 1 are not entitled to set off the taxes paid on them against their GST liability after 12 months, setting the deadline for June 30, 2018.


    On this issue the company has decided to approach the court for clarification

    Asking a question, Abhishek A Rastogi, a partner at Khaitan & Co told ET, “The question is can a law dictate how business is conducted and whether it can lay restrictions on the time frame of selling any products."

    Abhishek A RastogiCourtDelhi high courtdouble taxationfearing taxgodownsGoods and Services TaxGovernment of IndiaGSTLupinmovespetitionpre-GST stocksales taxTransitional creditVAT
    Source : with inputs

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok